Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by Defaulteron Apr 21, 2016 10:12pm
197 Views
Post# 24797219

Valeant wants Perrigo's Papa as its new CEO: CNBC

Valeant wants Perrigo's Papa as its new CEO: CNBC
3 minutes ago - Reuters Valeant wants Perrigo's Papa as its new CEO: CNBC, citing Dow Jones (Reuters) - Valeant Pharmaceuticals International Inc VRX.TO is seeking to name Perrigo Co Plc's (PRGO) Joseph Papa as its new chief executive, CNBC tweeted, citing Dow Jones. Valeant is finalizing a contract with the Perrigo CEO and an announcement of his appointment could come as soon as next week, a CNBC tweet said. (https://bit.ly/1Sf4Jdl) Valeant and Perrigo could not be reached immediately for comment outside regular business hours. (Reporting by Rama Venkat Raman in Bengaluru; Editing by Gopakumar Warrier)
<< Previous
Bullboard Posts
Next >>